Congratulations to Zac who was awarded an ETH grant!

We are thrilled to announce that GEML has been awarded an ETH grant to advance its pioneering research into the biological mechanisms driving phenotypic variability in human genetics. This project explores how cells respond to various genetic manipulations and how these adaptations influence phenotypic outcomes. By unraveling these processes, we aim to uncover key factors that shape disease traits and open new avenues for therapeutic intervention. This achievement highlights GEML’s leadership in cutting-edge genome engineering and our commitment to translating knowledge into transformative breakthroughs in human health. Stay tuned for updates on this impactful research!